comparemela.com

Latest Breaking News On - Dmitry morozov - Page 15 : comparemela.com

Russia Is Struggling To Make Sputnik V Doses. Why?

The problems are a warning to foreign partners – including in India – that are planning to mass produce the vaccine.

Moscow
Moskva
Russia
Caracas
Distrito-federal
Venezuela
United-states
India
Brazil
China
Russian
America

Big promises, few doses: Why Russia's struggling to make Sputnik V doses

President Vladimir Putin has trumpeted the vaccine around the world, and said in March that Russia had signed agreements for the production of 700 million doses of Sputnik V vaccine abroad. But Russia had produced just 33 million vaccines as of May 12 and exported fewer than 15 million.

China
Moscow
Moskva
Russia
United-states
India
Brazil
Russian
America
Vikram-punia
Vladimir-putin
Alexei-repik

COVID-19 vaccine: Here's why Russia is struggling to make Sputnik V doses

COVID-19 vaccine: Here s why Russia is struggling to make Sputnik V doses The Russian Direct Investment Fund (RDIF), which is responsible for marketing the vaccine abroad, said the manufacturing capacity for Sputnik V was increasing globally as new manufacturers come on board. Reuters | May 14, 2021 | Updated 14:36 IST Transforming the site of what once was a Soviet-era car factory into a state-of-the-art facility churning out Russia s COVID-19 vaccine Sputnik V was the easy bit. Making doses in bulk, finding qualified staff and getting equipment have been much bigger headaches for Moscow-based biotech firm R-Pharm and other private Russian companies picked to make the country s flagship shot to fight the pandemic.

China
Moscow
Moskva
Russia
United-states
India
Brazil
Russian
America
Vikram-punia
Vladimir-putin
Alexei-repik

INSIGHT-Big promises, few doses: why Russia's struggling to make Sputnik V doses

INSIGHT-Big promises, few doses: why Russia s struggling to make Sputnik V doses Reuters 3 hrs ago Russia has touted Sputnik V vaccine around world Vaccine production and exports lower than expected Manufacturers face a series of big challenges Hurdles serve as a warning to foreign partners (Updates to add comment from Russia s industry ministry) By Polina Nikolskaya and Polina Ivanova MOSCOW, May 14 (Reuters) - Transforming the site of what once was a Soviet-era car factory into a state-of-the-art facility churning out Russia s COVID-19 vaccine Sputnik V was the easy bit. Making doses in bulk, finding qualified staff and getting equipment have been much bigger headaches for Moscow-based biotech firm R-Pharm and other private Russian companies picked to make the country s flagship shot to fight the pandemic.

China
Moscow
Moskva
Russia
United-states
India
Brazil
Russian
America
Vikram-punia
Polina-nikolskaya
Josephine-mason

Энергетики банкротят поселок таун-хаусов в Новосибирске

Энергетики банкротят поселок таун-хаусов в Новосибирске
tayga.info - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tayga.info Daily Mail and Mail on Sunday newspapers.

Ob-reservoir
Russia-general
Russia
Akademgorodok
Novosibirskaya-oblast
Novosibirsk
Olga-senik
Dmitry-morozov
May-energy
Novosibirskc-novosibirsk
Territory-united
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.